Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Calliditas Therapeutics AB (publ)
  6. News
  7. Summary
    CALTX   SE0010441584

CALLIDITAS THERAPEUTICS AB (PUBL)

(CALTX)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 10/20 03:58:52 am
94.6 SEK   -1.15%
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/13European ADRs Move Higher in Wednesday Trading
MT
10/12European ADRs Slightly Higher Tuesday Morning, Led by Biotechs
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Nudge Lower in Tuesday Trading

09/14/2021 | 11:12am EDT


© MT Newswires 2021
All news about CALLIDITAS THERAPEUTICS AB (PUBL)
10/19European ADRs 0.6% Higher Tuesday Morning
MT
10/13European ADRs Move Higher in Wednesday Trading
MT
10/12European ADRs Slightly Higher Tuesday Morning, Led by Biotechs
MT
10/11European ADRs Move Higher in Monday Trading
MT
10/07European ADRs Climb Higher in Thursday Trading
MT
10/07CALLIDITAS THERAPEUTICS : Acquires Remaining Equity in Biotech Firm Genkyotex
MT
10/07CALLIDITAS THERAPEUTICS : Acquires Remaining Stake in Genkyotex
MT
10/07CALLIDITAS THERAPEUTICS : announces acquisition of remaining Genkyotex minority shares
AQ
10/05European ADRs Climb 1.3% Tuesday as Banks, Techs Lead
MT
09/21European ADRs Move Higher in Tuesday Trading
MT
More news
Analyst Recommendations on CALLIDITAS THERAPEUTICS AB (PUBL)
More recommendations
Financials
Sales 2021 3,10 M 0,36 M 0,36 M
Net income 2021 -665 M -77,2 M -77,2 M
Net cash 2021 488 M 56,7 M 56,7 M
P/E ratio 2021 -8,19x
Yield 2021 -
Capitalization 5 009 M 581 M 581 M
EV / Sales 2021 1 456x
EV / Sales 2022 8,07x
Nbr of Employees 54
Free-Float 88,4%
Chart CALLIDITAS THERAPEUTICS AB (PUBL)
Duration : Period :
Calliditas Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CALLIDITAS THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 95,70 SEK
Average target price 170,00 SEK
Spread / Average Target 77,6%
EPS Revisions
Managers and Directors
Renée Julie Elisabet Aguiar-Lucander Chief Executive Officer
Fredrik Johansson Chief Financial Officer
Elmar J. Schnee Chairman
Johan Erik Häggblad Chief Scientific Officer
Richard Philipson Chief Medical Officer